Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Ravindra Singh Rawat & Sanjit Kumar. (2023) Understanding the mode of inhibition and molecular interaction of taxifolin with human adenosine deaminase. Journal of Biomolecular Structure and Dynamics 41:2, pages 377-385.
Read now
Read now
Articles from other publishers (18)
Sarah Maloney, Stephen J. Clarke, Sumit Sahni, Amanda Hudson, Emily Colvin, Anubhav Mittal, Jaswinder Samra & Nick Pavlakis. (2023) The role of diagnostic, prognostic, and predictive biomarkers in the management of early pancreatic cancer. Journal of Cancer Research and Clinical Oncology 149:14, pages 13437-13450.
Crossref
Crossref
Raghuvirsinh Parmar, Sadhana Rajput & Arivozhi Mohan. (2023) Identification, isolation, and structure elucidation of novel forced degradation products of nelarabine. SEPARATION SCIENCE PLUS 6:5.
Crossref
Crossref
Liang Zhang, Kangjing Qi, Jie Xu, Yan Xing, Xuejian Wang, Ling Tong, Zengguo He, Wenfang Xu, Xiaoyang Li & Yuqi Jiang. (2023) Design, Synthesis, and Anti-Cancer Evaluation of Novel Cyclic Phosphate Prodrug of Gemcitabine. Journal of Medicinal Chemistry 66:6, pages 4150-4166.
Crossref
Crossref
Yujia Chen, Yuduo Guo, Shenglun Li, Jiacheng Xu, Weihai Ning, Chao Zhao, Jun Wang, Yanming Qu, Mingshan Zhang, Wanlu Zhou, Qinghua Cui & Hongwei Zhang. (2023) Remdesivir inhibits the progression of glioblastoma by enhancing endoplasmic reticulum stress. Biomedicine & Pharmacotherapy 157, pages 114037.
Crossref
Crossref
Galal H. Elgemeie & Reham A. Mohamed-Ezzat. 2022. New Strategies Targeting Cancer Metabolism. New Strategies Targeting Cancer Metabolism
107
142
.
Joel Morris, Donn G. Wishka, Omar D. Lopez, Vladimir Rudchenko, Guangfei Huang, Sierra N. Hoffman, Suzanne Borgel, Kyle Georgius, John Carter, Howard Stotler, Mark W. Kunkel, Jerry M. Collins, Melinda G. Hollingshead & Beverly A. Teicher. (2021) F-aza-T-dCyd (NSC801845), a Novel Cytidine Analog, in Comparative Cell Culture and Xenograft Studies with the Clinical Candidates T-dCyd, F-T-dCyd, and Aza-T-dCyd. Molecular Cancer Therapeutics 20:4, pages 625-631.
Crossref
Crossref
Vera Simonenko, Xiaoyong Lu, Eric Roesch, Daniel Mutisya, Chunbo Shao, Qian Sun, Athéna Patterson-Orazem, Marcus McNair, Aranganathan Shanmuganathan, Patrick Lu & David M Evans. (2020) A novel siRNA–gemcitabine construct as a potential therapeutic for treatment of pancreatic cancer. NAR Cancer 2:3.
Crossref
Crossref
Jing Sun, Dan Yang, Shi-He Cui, Hai-Tao Zhang, Yu Fu, Jian-Cheng Wang & Qiang Zhang. (2019) Enhanced anti-tumor efficiency of gemcitabine prodrug by FAPα-mediated activation. International Journal of Pharmaceutics 559, pages 48-57.
Crossref
Crossref
Eduardo Sánchez-Lara, Samuel Treviño, Brenda L. Sánchez-Gaytán, Enrique Sánchez-Mora, María Eugenia Castro, Francisco J. Meléndez-Bustamante, Miguel A. Méndez-Rojas & Enrique González-Vergara. (2018) Decavanadate Salts of Cytosine and Metformin: A Combined Experimental-Theoretical Study of Potential Metallodrugs Against Diabetes and Cancer. Frontiers in Chemistry 6.
Crossref
Crossref
Jean A. Bernatchez, Zunhua Yang, Michael Coste, Jerry Li, Sungjun Beck, Yan Liu, Alex E. Clark, Zhe Zhu, Lucas A. Luna, Christal D. Sohl, Byron W. Purse, Rongshi Li & Jair L. Siqueira-Neto. (2018) Development and Validation of a Phenotypic High-Content Imaging Assay for Assessing the Antiviral Activity of Small-Molecule Inhibitors Targeting Zika Virus. Antimicrobial Agents and Chemotherapy 62:10.
Crossref
Crossref
Shuxian Chen, Xu Wang, Xianghui Ye & Jian Jin. (2017) Gemcitabine and Doxorubicin Combination Enhance the Cytotoxic Effect to Pancreatic Cancer Cells BxPC3 and PANC1 through UMP/CMP Kinase 1. Journal of Biosciences and Medicines 05:10, pages 64-74.
Crossref
Crossref
Jadd Shelton, Xiao Lu, Joseph A. Hollenbaugh, Jong Hyun Cho, Franck Amblard & Raymond F. Schinazi. (2016) Metabolism, Biochemical Actions, and Chemical Synthesis of Anticancer Nucleosides, Nucleotides, and Base Analogs. Chemical Reviews 116:23, pages 14379-14455.
Crossref
Crossref
Pedro Merino, Ignacio Delso, Tomás Tejero, Mattia Ghirardello & Verónica Juste-Navarro. (2016) Nucleoside Diphosphate Sugar Analogues that Target Glycosyltransferases. Asian Journal of Organic Chemistry 5:12, pages 1413-1427.
Crossref
Crossref
A.S. Efremova, S.I. Shram, M.S. Drenichev, G.A. Posypanova, N.F. Myasoedov & S.N. Mihaylov. (2015) The selective toxic effect of dialdehyde derivatives of the pyrimidine nucleosides on human tumor cells. Biomeditsinskaya Khimiya 61:4, pages 497-502.
Crossref
Crossref
Thomas S. Frank, Xiaotian Sun, Yuqing Zhang, Jingxuan Yang, William E. Fisher, Marie-Claude Gingras & Min Li. (2015) Genomic profiling guides the choice of molecular targeted therapy of pancreatic cancer. Cancer Letters 363:1, pages 1-6.
Crossref
Crossref
A. S. Efremova, S. I. Shram, M. S. Drenichev, G. A. Posypanova, N. F. Myasoedov & S. N. Mikhailov. (2014) The selective toxic effect of dialdehyde derivatives of pyrimidine nucleosides on human ovarian cancer cells. Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry 8:4, pages 318-322.
Crossref
Crossref
Z.J. LIAO, Y.H. GUO, Z. ZHAO, J.T. YAO, R. XU & K.J. NAN. (2014) Gemcitabine inhibits the micrometastasis of non-small cell lung cancer by targeting the EpCAM-positive circulating tumor cells via the HGF/cMET pathway. International Journal of Oncology 45:2, pages 651-658.
Crossref
Crossref
Tamar Safra, Noam Asna, Anat Veizman, Shulem Shpigel, Dianna Matcejevsky, Moshe Inbar & Dan Grisaru. (2014) The combination of gemcitabine and carboplatin shows similar efficacy in the treatment of platinum-resistant and platinum-sensitive recurrent epithelial ovarian cancer patients. Anti-Cancer Drugs 25:3, pages 340-345.
Crossref
Crossref